Literature DB >> 15127152

[Regulation of spinal nociceptin expression by neuropathic pain].

A Gabriel1, C Pietruck, T Meuser, M Sharma, P Pierce Palmer, S Grond.   

Abstract

Nociceptin is the endogenous ligand of a new opioid receptor, the opioid receptor-like-1 (ORL1) receptor. Chronic inflammatory pain causes an increase in the expression of nociceptin and the ORL1 receptor in the dorsal horn of rat spinal cord, thus indicating an involvement of the endogenous nociceptin/ORL1 system in mechanisms of pathological pain. This study investigates the influence of neuropathic pain on the expression of nociceptin using immunohistochemistry. To induce neuropathic pain, a ligation of the sciatic nerve was performed in 12 rats under general anesthesia. A sham operation was performed in 12 rats of the control group. Nerve ligation caused a significant ipsilateral thermal hyperalgesia, a typical sign of neuropathic pain. The paw withdrawal latency was decreased by 45.7+/-4.9% ( p<0.05) at day 5 and by 37.3+/-1.8% ( p<0.05) at day 10. Although hyperalgesia was fully present after 5 days, no changes in nociceptin immunoreactivity in the lumbar spinal cord were detected at this time point. Ten days after nerve ligation, there was a 2.46+/-0.38 fold ( p<0.05) bilateral increase in nociceptin immunoreactivity in the lamina superficiales (I and II), with a notable increase in the inner lamina II at the level of L4. Further investigations are necessary to elucidate the relationship between neuropathic pain, the nociceptin-ORL1 receptor system and potential therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127152     DOI: 10.1007/s00101-004-0688-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  39 in total

1.  Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma.

Authors:  A B Malmberg; C Chen; S Tonegawa; A I Basbaum
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

2.  Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception.

Authors:  A Rosén; T Lundeberg; B Bytner; I Nylander
Journal:  Brain Res       Date:  2000-02-28       Impact factor: 3.252

3.  Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats.

Authors:  T P Malan; M H Ossipov; L R Gardell; M Ibrahim; D Bian; J Lai; F Porreca
Journal:  Pain       Date:  2000-05       Impact factor: 6.961

4.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; S J Watson
Journal:  J Comp Neurol       Date:  1999-04-19       Impact factor: 3.215

5.  Effects of pre-emptively administered nociceptin on the development of thermal hyperalgesia induced by two models of experimental mononeuropathy in the rat.

Authors:  T Yamamoto; S Ohtori; T Chiba
Journal:  Brain Res       Date:  2000-07-21       Impact factor: 3.252

6.  Spinal analgesic activity of orphanin FQ/nociceptin and its fragments.

Authors:  M A King; G C Rossi; A H Chang; L Williams; G W Pasternak
Journal:  Neurosci Lett       Date:  1997-02-21       Impact factor: 3.046

7.  Analysis and treatment of different types of neuropathic cancer pain.

Authors:  Petra Stute; Jens Soukup; Matthias Menzel; Rainer Sabatowski; Stefan Grond
Journal:  J Pain Symptom Manage       Date:  2003-12       Impact factor: 3.612

8.  Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.

Authors:  Luca Briscini; Laura Corradini; Ennio Ongini; Rosalia Bertorelli
Journal:  Eur J Pharmacol       Date:  2002-06-28       Impact factor: 4.432

9.  Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?

Authors:  Hanns Ulrich Zeilhofer; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2003-04-29       Impact factor: 4.030

10.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  1 in total

1.  [Expression und function of the ORL-1 receptor on human leukocytes].

Authors:  C Krüger; L Köthe; A Struppert; C Pietruck; A Simm; S Grond
Journal:  Schmerz       Date:  2006-11       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.